Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?

Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 1

Abstract

Authors and Affiliations

Gesira Florentino, Helma Cotrim, André Florentino, Consuelo Padilha, Manoel Medeiros-Neto, Gerson Bragagnol, Paulo Schwingel

Keywords

Related Articles

Prevalence of type 2 diabetes mellitus and chronic liver disease: A retrospective study of the association of two increasingly common diseases in Mexico

Background. Recent studies have demonstrated a relationship between insulin resistance (IR) and type 2 diabetes mellitus (T2DM). The aim of this study was to determine the prevalence of T2DM among patients with liver dis...

The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study

Background and rationale. Cirrhosis is responsible for significant health-care costs and morbidity. This study aims to evaluate the burden of illness associated with cirrhosis, its impact on the universal coverage public...

Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants

Background. 373 black participants had elevated screening and post-screening serum ferritin (SF) (> 300 μg/L men; > 200 μg/L women). Material and methods. We retrospectively studied SF and post-screening age; sex; body m...

Hepatolithiasis with secondary cholangitis and supernumerary left hepatic lobe

We report the case of a 31-year old woman with recurrent cholangitis secondary to hepatolithiasis. The stones were composed of calcium bilirrubinate. The patient also had a supernumerary hepatic lobe connected to the inf...

Download PDF file
  • EP ID EP78115
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

Gesira Florentino, Helma Cotrim, André Florentino, Consuelo Padilha, Manoel Medeiros-Neto, Gerson Bragagnol, Paulo Schwingel (2012). Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?. Annals of Hepatology, 11(1), 147-149. https://europub.co.uk/articles/-A-78115